Cargando…

GYY4137 Regulates Extracellular Matrix Turnover in the Diabetic Kidney by Modulating Retinoid X Receptor Signaling

Diabetic kidney is associated with an accumulation of extracellular matrix (ECM) leading to renal fibrosis. Dysregulation of retinoic acid metabolism involving retinoic acid receptors (RARs) and retinoid X receptors (RXRs) has been shown to play a crucial role in diabetic nephropathy (DN). Furthermo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Juin, Subir Kumar, Pushpakumar, Sathnur, Sen, Utpal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533431/ https://www.ncbi.nlm.nih.gov/pubmed/34680110 http://dx.doi.org/10.3390/biom11101477

Ejemplares similares

GYY4137, a Hydrogen Sulfide Donor Modulates miR194-Dependent Collagen Realignment in Diabetic Kidney
por: John, AM Sashi Papu, et al.
Publicado: (2017)

Hydrogen Sulfide Donor GYY4137 Protects against Myocardial Fibrosis
por: Meng, Guoliang, et al.
Publicado: (2015)

Methylation-dependent antioxidant-redox imbalance regulates hypertensive kidney injury in aging
por: Pushpakumar, Sathnur, et al.
Publicado: (2020)

Glucosidase inhibitor, Nimbidiol ameliorates renal fibrosis and dysfunction in type-1 diabetes
por: Juin, Subir Kumar, et al.
Publicado: (2022)

Experimental research into the potential therapeutic effect of GYY4137 on Ovariectomy-induced osteoporosis
por: Xu, Zhong-Shi, et al.
Publicado: (2018)

The protective effects of GYY4137 on ipsilateral testicular injury in experimentally varicocele-induced rats
por: Ning, Jin-Zhuo, et al.
Publicado: (2018)

A H(2)S Donor GYY4137 Exacerbates Cisplatin-Induced Nephrotoxicity in Mice
por: Liu, Mi, et al.
Publicado: (2016)

The Anxiolytic and Antidepressant Effects of Diallyl Disulfide and GYY4137 in Animals with Chronic Neuropathic Pain
por: Bai, Xue, et al.
Publicado: (2021)

Synthesis of Sulfur-35-Labeled Trisulfides and GYY-4137 as Donors of Radioactive Hydrogen Sulfide
por: Brown, Eric M., et al.
Publicado: (2023)

GYY4137 Attenuates Sodium Deoxycholate-Induced Intestinal Barrier Injury Both In Vitro and In Vivo
por: Chen, Zeyang, et al.
Publicado: (2019)

Hydrogen Sulfide Protects Hyperhomocysteinemia-Induced Renal Damage by Modulation of Caveolin and eNOS Interaction
por: Pushpakumar, Sathnur, et al.
Publicado: (2019)

GYY4137 protects against myocardial ischemia and reperfusion injury by attenuating oxidative stress and apoptosis in rats
por: Meng, Guoliang, et al.
Publicado: (2015)

GYY4137 Promotes Mice Feeding Behavior via Arcuate Nucleus Sulfur-Sulfhydrylation and AMPK Activation
por: Zhou, Jun, et al.
Publicado: (2018)

Hydrogen Sulfide Donor GYY4137 Rescues NRF2 Activation in Respiratory Syncytial Virus Infection
por: de Mello, Aline Haas, et al.
Publicado: (2022)

The Slow-Releasing Hydrogen Sulfide Donor, GYY4137, Exhibits Novel Anti-Cancer Effects In Vitro and In Vivo
por: Lee, Zheng Wei, et al.
Publicado: (2011)

Improved growth of pea, lettuce, and radish plants using the slow release of hydrogen sulfide from GYY-4137
por: Carter, Justin M., et al.
Publicado: (2018)

TRPA1 Ion Channel Determines Beneficial and Detrimental Effects of GYY4137 in Murine Serum-Transfer Arthritis
por: Bátai, István Z., et al.
Publicado: (2019)

Increased circulating peroxiredoxin-4 in sepsis model rats involves secretion from hepatocytes and is mitigated by GYY4137
por: Unuma, Kana, et al.
Publicado: (2019)

Matrix metalloproteinase inhibition mitigates renovascular remodeling in salt-sensitive hypertension
por: Pushpakumar, Sathnur B, et al.
Publicado: (2013)

Upregulation of Tolerogenic Pathways by the Hydrogen Sulfide Donor GYY4137 and Impaired Expression of H(2)S-Producing Enzymes in Multiple Sclerosis
por: Lazarević, Milica, et al.
Publicado: (2020)

Toll-like Receptor 4 Deficiency Reduces Oxidative Stress and Macrophage Mediated Inflammation in Hypertensive Kidney
por: Pushpakumar, Sathnur, et al.
Publicado: (2017)

The complex effects of the slow-releasing hydrogen sulfide donor GYY4137 in a model of acute joint inflammation and in human cartilage cells
por: Li, Ling, et al.
Publicado: (2013)

GYY4137-Derived Hydrogen Sulfide Donates Electrons to the Mitochondrial Electron Transport Chain via Sulfide: Quinone Oxidoreductase in Endothelial Cells
por: Star, Bastiaan S., et al.
Publicado: (2023)

GYY4137, an H(2)S Slow-Releasing Donor, Prevents Nitrative Stress and α-Synuclein Nitration in an MPTP Mouse Model of Parkinson’s Disease
por: Hou, Xiaoou, et al.
Publicado: (2017)

GYY4137 and Sodium Hydrogen Sulfide Relaxations Are Inhibited by L-Cysteine and K(V)7 Channel Blockers in Rat Small Mesenteric Arteries
por: Abramavicius, Silvijus, et al.
Publicado: (2021)

Folic Acid Mitigates Angiotensin-II-Induced Blood Pressure and Renal Remodeling
por: Pushpakumar, Sathnur B., et al.
Publicado: (2013)

A New Slow Releasing, H(2)S Generating Compound, GYY4137 Relaxes Spontaneous and Oxytocin-Stimulated Contractions of Human and Rat Pregnant Myometrium
por: Robinson, Hayley, et al.
Publicado: (2012)

The H(2)S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide
por: Lazarević, Milica, et al.
Publicado: (2018)

Vasoactive Effects of Chronic Treatment with Fructose and Slow-Releasing H(2)S Donor GYY-4137 in Spontaneously Hypertensive Rats: The Role of Nitroso and Sulfide Signalization
por: Berenyiova, Andrea, et al.
Publicado: (2022)

Hydrogen sulfide donor GYY4137 suppresses proliferation of human colorectal cancer Caco-2 cells by inducing both cell cycle arrest and cell death
por: Sakuma, Satoru, et al.
Publicado: (2019)

The H(2)S-Releasing Naproxen Derivative ATB-346 and the Slow-Release H(2)S Donor GYY4137 Reduce Intestinal Inflammation and Restore Transit in Postoperative Ileus
por: Van Dingenen, Jonas, et al.
Publicado: (2019)

GYY4137 a H(2)S donor, attenuates ipsilateral epididymis injury in experimentally varicocele-induced rats via activation of the PI3K/Akt pathway
por: Xia, Yu-qi, et al.
Publicado: (2019)

Of Retinoids and Organotins: The Evolution of the Retinoid X Receptor in Metazoa
por: Fonseca, Elza, et al.
Publicado: (2020)

COVID-19 Mimics Pulmonary Dysfunction in Muscular Dystrophy as a Post-Acute Syndrome in Patients
por: Tyagi, Suresh C., et al.
Publicado: (2022)

Retinoid X Receptor Antagonists
por: Watanabe, Masaki, et al.
Publicado: (2018)

Diabetic Nephropathy and Gaseous Modulators
por: Juin, Subir Kumar, et al.
Publicado: (2023)

Transcriptional Regulation of Flotillins by the Extracellularly Regulated Kinases and Retinoid X Receptor Complexes
por: Banning, Antje, et al.
Publicado: (2012)

Renal Denervation Helps Preserve the Ejection Fraction by Preserving Endocardial-Endothelial Function during Heart Failure
por: Pushpakumar, Sathnur, et al.
Publicado: (2023)

Retinoic Acid and Retinoid X Receptors
por: Schubert, Michael, et al.
Publicado: (2023)

Therapeutic Potential of Retinoid X Receptor Modulators for the Treatment of the Metabolic Syndrome
por: Pinaire, Jane A., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_e75gm1lke0h6ates3b1ehriqtc